These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 29020849)
21. Practical aspects in size and morphology characterization of drug-loaded nano-liposomes. Peretz Damari S; Shamrakov D; Varenik M; Koren E; Nativ-Roth E; Barenholz Y; Regev O Int J Pharm; 2018 Aug; 547(1-2):648-655. PubMed ID: 29913218 [TBL] [Abstract][Full Text] [Related]
22. Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity. Gkionis L; Campbell RA; Aojula H; Harris LK; Tirella A Int J Pharm; 2020 Nov; 590():119926. PubMed ID: 33010397 [TBL] [Abstract][Full Text] [Related]
23. Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy. Zhan W; Wang CH J Control Release; 2018 Sep; 285():212-229. PubMed ID: 30009891 [TBL] [Abstract][Full Text] [Related]
24. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160 [TBL] [Abstract][Full Text] [Related]
25. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells. Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H Biomaterials; 2013 Jul; 34(22):5617-27. PubMed ID: 23623323 [TBL] [Abstract][Full Text] [Related]
26. Tumor-penetrating peptide mediation: an effective strategy for improving the transport of liposomes in tumor tissue. Yan Z; Yang Y; Wei X; Zhong J; Wei D; Liu L; Xie C; Wang F; Zhang L; Lu W; He D Mol Pharm; 2014 Jan; 11(1):218-25. PubMed ID: 24325555 [TBL] [Abstract][Full Text] [Related]
27. Microfluidic synthesis of multifunctional liposomes for tumour targeting. Ran R; Middelberg APJ; Zhao CX Colloids Surf B Biointerfaces; 2016 Dec; 148():402-410. PubMed ID: 27639490 [TBL] [Abstract][Full Text] [Related]
28. Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor. Tang H; Chen X; Rui M; Sun W; Chen J; Peng J; Xu Y Mol Pharm; 2014 Oct; 11(10):3242-50. PubMed ID: 25181533 [TBL] [Abstract][Full Text] [Related]
29. Liposomalization of oxaliplatin induces skin accumulation of it, but negligible skin toxicity. Nishida K; Kashiwagi M; Shiba S; Muroki K; Ohishi A; Doi Y; Ando H; Ishida T; Nagasawa K Toxicol Appl Pharmacol; 2017 Dec; 337():76-84. PubMed ID: 29054682 [TBL] [Abstract][Full Text] [Related]
30. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy? Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468 [TBL] [Abstract][Full Text] [Related]
31. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy. Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944 [TBL] [Abstract][Full Text] [Related]
32. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. Pasut G; Paolino D; Celia C; Mero A; Joseph AS; Wolfram J; Cosco D; Schiavon O; Shen H; Fresta M J Control Release; 2015 Feb; 199():106-13. PubMed ID: 25499917 [TBL] [Abstract][Full Text] [Related]
33. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Gabizon A; Martin F Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957 [TBL] [Abstract][Full Text] [Related]
34. Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges. Al-Amin MD; Bellato F; Mastrotto F; Garofalo M; Malfanti A; Salmaso S; Caliceti P Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111100 [TBL] [Abstract][Full Text] [Related]
37. Sequential treatment of oxaliplatin-containing PEGylated liposome together with S-1 improves intratumor distribution of subsequent doses of oxaliplatin-containing PEGylated liposome. Nakamura H; Doi Y; Abu Lila AS; Nagao A; Ishida T; Kiwada H Eur J Pharm Biopharm; 2014 May; 87(1):142-51. PubMed ID: 24361534 [TBL] [Abstract][Full Text] [Related]
38. Chain-Length- and Saturation-Tuned Mechanics of Fluid Nanovesicles Direct Tumor Delivery. Dai Z; Yu M; Yi X; Wu Z; Tian F; Miao Y; Song W; He S; Ahmad E; Guo S; Zhu C; Zhang X; Li Y; Shi X; Wang R; Gan Y ACS Nano; 2019 Jul; 13(7):7676-7689. PubMed ID: 31187973 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method. Jaradat E; Weaver E; Meziane A; Lamprou DA Mol Pharm; 2023 Dec; 20(12):6184-6196. PubMed ID: 37931072 [TBL] [Abstract][Full Text] [Related]
40. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]